Who are Predicta Biosciences's investors?

Predicta Biosciences's investors include Illumina Ventures, The Engine Ventures.

Where is Predicta Biosciences headquartered?

Predicta Biosciences is headquartered in Cambridge, US.

Predicta Biosciences

Cambridge, US · Founded 2023 · 21 employees on LinkedIn · 2 known investors

Find your way into Predicta Biosciences

720 people in our graph share verified history with the Predicta Biosciences team — schools, employers, funds. One of them is your warm intro.

Anika Guptaunlockedknows Irene Ghobrial · together at Broad Institute of MIT and Harvard (overlapped)

×5knows the team · via Broad Institute of MIT and Harvard

knows the team · via Dana-Farber Cancer Institute

×3knows the team · via Harvard Business School

knows the team · via Harvard Medical School

knows the team · via Bucknell University

Predicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response. Its diagnostics serve clinicians, researchers, and pharmaceutical partners working in hematological malignancies such as multiple myeloma.

Biotech Digital Health Medical Devices

Founders & leadership

Predicta Biosciences was founded in 2023 by Irene Ghobrial, Kenneth Anderson, Gad Getz, Romanos Sklavenitis-Pistofidis, and Keith Flaherty.

Irene Ghobrial inCo-founderIrene Ghobrial is a physician-scientist with expertise in multiple myeloma and Waldenström macroglobulinemia, including precursor conditions such as monoclonal gammopathy of undetermined significance and smoldering disease.

Kenneth AndersonCo-founder

Gad GetzCo-founder

Romanos Sklavenitis-PistofidisCo-founder

Keith FlahertyCo-founder

Brian McKernan inCEOBrian McKernan is CEO of Predictabiosciences, a molecular diagnostics platform for blood cancer care. He previously served as CEO of Fluent BioSciences and co-founded multiple life sciences companies including Courtagen Life Sciences, Medicinal Genomics, and Agencourt Bioscience, with three exits; he holds an MBA in finance from Columbia Business School.

Investors · 2

Illumina Ventures✓ verifiedFoster City

The Engine VenturesCambridge

Competitors · 5

by search overlap

Labcorp21 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.

IQVIA19 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.

Precede15 shared keywordsPrecede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials. The platform enables non-invasive patient selection and longitudinal tracking of disease mechanisms in oncology and other therapeutic areas.

Predictive Oncology14 shared keywordsPredictive Oncology develops drug discovery solutions for biopharma companies that combine artificial intelligence with a proprietary biobank of over 150,000 tumor samples to accelerate oncology drug development and improve therapeutic outcomes for cancer patients.

Precision BioSciences12 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

Companies competing with Predicta Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Predicta Biosciences do?: Predicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response. Its diagnostics serve clinicians, researchers, and pharmaceutical partners working in hematological malignancies such as multiple myeloma.
Who founded Predicta Biosciences?: Predicta Biosciences was founded by Irene Ghobrial, Kenneth Anderson, Gad Getz, Romanos Sklavenitis-Pistofidis, Keith Flaherty in 2023.
Who are Predicta Biosciences's investors?: Predicta Biosciences's investors include Illumina Ventures, The Engine Ventures.
Where is Predicta Biosciences headquartered?: Predicta Biosciences is headquartered in Cambridge, US.